Fig. 1: Acute and chronic graft-versus-host disease in sAML patients undergoing haplo-HSCT with PTCy from peripheral blood stem cells (PB) compared to bone marrow (BM) grafts. | Bone Marrow Transplantation

Fig. 1: Acute and chronic graft-versus-host disease in sAML patients undergoing haplo-HSCT with PTCy from peripheral blood stem cells (PB) compared to bone marrow (BM) grafts.

From: Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

Fig. 1: Acute and chronic graft-versus-host disease in sAML patients undergoing haplo-HSCT with PTCy from peripheral blood stem cells (PB) compared to bone marrow (BM) grafts.

a aGVHD grade II-IV; b aGVHD grade III-IV; c cGVHD; d ext cGVHD. aGVHD acute graft-versus-host disease, cGVHD chronic graft-versus-host disease, ext extensive, BM bone marrow, PB peripheral blood, sAML secondary acute myeloid leukemia, haplo-HSCT haploidentical hematopoietic stem cell transplantation, PTCy post-transplant cyclophosphamide, aHR multivariable adjusted hazard ratio.

Back to article page